OncoMed Pharmaceuticals' IPO

OncoMed Pharmaceuticals raised a round of funding on July 18, 2013. Investors include Public.

OncoMed Pharmaceuticals is a clinical-stage company focused on discovering and developing therapeutics targeting cancer stem cells, or CSCs, which are the subpopulation of cells in a tumor responsible…

Articles about OncoMed Pharmaceuticals' IPO: